Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Reese Koç

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Best Practice & Research. Clinical Haematology|April 24, 2025
Creating a GMP cell processing program: A focus on quality and regulationDarshan Patel, Jane Reese Koç, Folashade Otegbeye
Cytotherapy|July 1, 2020
Cryopreservation of hematopoietic cells using a pre-constituted, protein-free cryopreservative solution with 5% dimethyl sulfoxideTabatha Trummer, Robert Fox, Jane Reese Koç, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 7, 2018
Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosisSarah M Planchon, Karen T Lingas, Jane Reese Koç, et al.
Cytotherapy|June 8, 2010
Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experienceAdrian P Gee, Sara Richman, April Durett, et al.
Transfusion|February 11, 2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studySara Richman, Adrian P Gee, David H McKenna, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Haematology|April 24, 2025
Creating a GMP cell processing program: A focus on quality and regulationDarshan Patel, Jane Reese Koç, Folashade Otegbeye
Cytotherapy|July 1, 2020
Cryopreservation of hematopoietic cells using a pre-constituted, protein-free cryopreservative solution with 5% dimethyl sulfoxideTabatha Trummer, Robert Fox, Jane Reese Koç, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 7, 2018
Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosisSarah M Planchon, Karen T Lingas, Jane Reese Koç, et al.
Cytotherapy|June 8, 2010
Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experienceAdrian P Gee, Sara Richman, April Durett, et al.
Transfusion|February 11, 2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studySara Richman, Adrian P Gee, David H McKenna, et al.
Pageof 1